JP2012507491A5 - - Google Patents

Download PDF

Info

Publication number
JP2012507491A5
JP2012507491A5 JP2011533761A JP2011533761A JP2012507491A5 JP 2012507491 A5 JP2012507491 A5 JP 2012507491A5 JP 2011533761 A JP2011533761 A JP 2011533761A JP 2011533761 A JP2011533761 A JP 2011533761A JP 2012507491 A5 JP2012507491 A5 JP 2012507491A5
Authority
JP
Japan
Prior art keywords
chain
straight
carbon atoms
substituted
hydrocarbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011533761A
Other languages
English (en)
Japanese (ja)
Other versions
JP5798486B2 (ja
JP2012507491A (ja
Filing date
Publication date
Priority claimed from FR0857496A external-priority patent/FR2937972B1/fr
Application filed filed Critical
Publication of JP2012507491A publication Critical patent/JP2012507491A/ja
Publication of JP2012507491A5 publication Critical patent/JP2012507491A5/ja
Application granted granted Critical
Publication of JP5798486B2 publication Critical patent/JP5798486B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011533761A 2008-11-04 2009-11-04 オキソアゼチジン誘導体、その調製方法、ならびにヒト医薬および化粧品におけるその使用 Expired - Fee Related JP5798486B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11113008P 2008-11-04 2008-11-04
US61/111,130 2008-11-04
FR0857496A FR2937972B1 (fr) 2008-11-04 2008-11-04 Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR0857496 2008-11-04
PCT/EP2009/064646 WO2010052253A1 (en) 2008-11-04 2009-11-04 Oxoazetidine derivatives, process for the preparation thereof and use thereof in human medicine and in cosmetics

Publications (3)

Publication Number Publication Date
JP2012507491A JP2012507491A (ja) 2012-03-29
JP2012507491A5 true JP2012507491A5 (enExample) 2015-08-20
JP5798486B2 JP5798486B2 (ja) 2015-10-21

Family

ID=40568303

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011533761A Expired - Fee Related JP5798486B2 (ja) 2008-11-04 2009-11-04 オキソアゼチジン誘導体、その調製方法、ならびにヒト医薬および化粧品におけるその使用

Country Status (13)

Country Link
US (2) US8871187B2 (enExample)
EP (1) EP2342194B1 (enExample)
JP (1) JP5798486B2 (enExample)
KR (1) KR101689042B1 (enExample)
CN (2) CN104387372B (enExample)
AR (1) AR074275A1 (enExample)
AU (1) AU2009312818B2 (enExample)
BR (1) BRPI0916069C1 (enExample)
CA (1) CA2738785C (enExample)
FR (1) FR2937972B1 (enExample)
MX (1) MX2011004068A (enExample)
RU (2) RU2671189C1 (enExample)
WO (1) WO2010052253A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2939135B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2969494B1 (fr) * 2010-12-22 2013-11-08 Expanscience Lab Extrait de parties aeriennes de gynandropsis gynandra ou cleome gynandra et compositions cosmetiques, dermatologiques le comprenant
FR2981933B1 (fr) * 2011-11-02 2013-11-15 Galderma Res & Dev Derives d'oxoazetidine, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
FR2984167B1 (fr) * 2011-12-16 2014-01-17 Galderma Res & Dev Association d'un agoniste des recepteurs des prostaglandines et d'un agoniste du recepteur mc1r pour le traitement et/ou la prevention de desordres de la pigmentation
EP2825187A1 (en) 2012-03-15 2015-01-21 Galderma Research & Development Combination of a mc1r receptor agonist and uvb for the treatment and/or prevention of pigmentation disorders
FR2992317B1 (fr) 2012-06-22 2016-05-13 Diverchim Procede de preparation de peptides chiraux
FR3027900B1 (fr) 2014-11-05 2018-02-23 Centre National De La Recherche Scientifique Utilisation de derives halogenes de l'histidine a titre de sel d'electrolyte dans une cellule photovoltaique a colorants
CA3252823A1 (en) 2016-06-13 2025-02-25 Gilead Sciences Inc Fxr (nr1h4) modulating compounds
SI3730487T1 (sl) 2016-06-13 2022-08-31 Gilead Sciences, Inc. Azetidinski derivati kot modulatorji FXR (NR1H4)
WO2018142318A1 (en) * 2017-02-01 2018-08-09 Clinuvel Pharmaceuticals Ltd Alpha-msh analogues used in the treatment of xeroderma pigmentosum
JP6906626B2 (ja) 2017-03-28 2021-07-21 ギリアード サイエンシーズ, インコーポレイテッド 肝疾患を処置するための治療的組み合わせ
EP3927683A1 (en) 2019-02-19 2021-12-29 Gilead Sciences, Inc. Solid forms of fxr agonists
WO2022056494A1 (en) 2020-09-14 2022-03-17 Regeneron Pharmaceuticals, Inc. Antibody-drug conjugates comprising glp1 peptidomimetics and uses thereof
JP2025512735A (ja) 2022-03-11 2025-04-22 リジェネロン ファーマシューティカルズ,インク. Glp1ペプチド模倣体を含む抗glp1r抗体係留型薬物コンジュゲートおよびその使用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY128261A (en) * 1992-10-27 2007-01-31 Merck Sharp & Dohme New substituted azetidinones as anti-inflammatory and antidegenerative agents
US6720001B2 (en) 1999-10-18 2004-04-13 Lipocine, Inc. Emulsion compositions for polyfunctional active ingredients
US6399651B1 (en) 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
JP2005511475A (ja) * 2001-03-02 2005-04-28 ブリストル−マイヤーズ スクイブ カンパニー メラノコルチン受容体のモジュレーターとして有用な化合物及びそれを含む製薬組成物
HUP0600103A2 (en) * 2001-03-02 2006-06-28 Bristol Myers Squibb Co Co-administration of melanocortin receptor agonist and phosphodiesterase inhibitor for treatment of cyclic-amp associated disorders
US6977264B2 (en) * 2001-07-25 2005-12-20 Amgen Inc. Substituted piperidines and methods of use
WO2005047253A1 (en) * 2003-11-12 2005-05-26 Lg Life Sciences Ltd. Melanocortin receptor agonists
CA2545644C (en) * 2003-11-12 2011-11-01 Lg Life Sciences Ltd. Melanocortin receptor agonists
FR2867684B1 (fr) 2004-03-18 2006-05-05 Galderma Sa Gel creme contenant de l'ivermectine

Similar Documents

Publication Publication Date Title
JP2012507491A5 (enExample)
ES2674480T3 (es) Método para preparar rebaudiósido A a partir de esteviósido
CO6220968A2 (es) Inhibidores heterociclicos de la aspartil proteasa
IN2014CN04648A (enExample)
AR112787A2 (es) Compuestos 1,5-difenil-penta-1,4-dien-3-ona
UA107791C2 (en) Pesticidal compositions
EA201270010A1 (ru) Диэлектрическая изоляционная среда
BR112013028028A2 (pt) método para preparar um hidrocarboneto de petróleo ou combustível derivado biologicamente líquido
CU24128B1 (es) Compuesto de benzoato conjugado a la hidrocodona (bz-hc)
UA100012C2 (en) Mousse
WO2014197928A8 (en) Biorefining method
UY31688A1 (es) Plaguicidas
CR20110581A (es) Preparación de solido
FR2946617B1 (fr) Dispositif d'actionnement d'une gouverne d'aeronef.
BR112015030088A2 (pt) aprimoramentos em ou referentes a compostos orgânicos
CL2008001577A1 (es) Metodo para tratar una leucemia positiva en un sujeto resistente a imatinib que comprende el uso de un compuesto derivado de 3-ciano-quinolina.
MX2012008125A (es) Herramienta para el recubrimiento electrolitico de cojinetes de deslizamiento.
WO2013110491A3 (de) Bauteil für ein haushaltsgerät
WO2009149982A3 (de) Vorrichtung zur freisetzung von ammoniak
GB2497020A (en) Retractable nose saddle
RU2012137206A (ru) Лигнангидроксилаза
MY171251A (en) Offshore structure
PL1865766T3 (pl) Gniazda dla niosek
TR201006830A2 (tr) Bir bulaşık makinesi
EP2546323A3 (en) Liquid fuel composition